These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 30038807)

  • 1. Urine miRNA as a potential biomarker for bladder cancer detection - a meta-analysis.
    Kutwin P; Konecki T; Borkowska EM; Traczyk-Borszyńska M; Jabłonowski Z
    Cent European J Urol; 2018; 71(2):177-185. PubMed ID: 30038807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic review of the clinical effectiveness and cost-effectiveness of photodynamic diagnosis and urine biomarkers (FISH, ImmunoCyt, NMP22) and cytology for the detection and follow-up of bladder cancer.
    Mowatt G; Zhu S; Kilonzo M; Boachie C; Fraser C; Griffiths TR; N'Dow J; Nabi G; Cook J; Vale L
    Health Technol Assess; 2010 Jan; 14(4):1-331, iii-iv. PubMed ID: 20082749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of diagnostic strategies for bladder cancer using computed tomography (CT) urography, flexible cystoscopy and voided urine cytology: results for 778 patients from a hospital haematuria clinic.
    Blick CG; Nazir SA; Mallett S; Turney BW; Onwu NN; Roberts IS; Crew JP; Cowan NC
    BJU Int; 2012 Jul; 110(1):84-94. PubMed ID: 22122739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miRNA-143 as a potential biomarker in the detection of bladder cancer: a meta-analysis.
    Li J; Li H; Yang Y; Sen Y; Ye J
    Future Oncol; 2024; 20(18):1275-1287. PubMed ID: 38722138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of urine fibronectin as a non-invasive diagnostic biomarker in bladder cancer patients: a systematic review and meta-analysis.
    Dong F; Shen Y; Xu T; Wang X; Gao F; Zhong S; Chen S; Shen Z
    World J Surg Oncol; 2018 Mar; 16(1):61. PubMed ID: 29562940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urine microRNAs as biomarkers for bladder cancer: a diagnostic meta-analysis.
    Cheng Y; Deng X; Yang X; Li P; Zhang X; Li P; Tao J; Lu Q; Wang Z
    Onco Targets Ther; 2015; 8():2089-96. PubMed ID: 26316777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative evaluation of the nuclear matrix protein, fibronectin, urinary bladder cancer antigen and voided urine cytology in the detection of bladder tumors.
    Eissa S; Swellam M; Sadek M; Mourad MS; El Ahmady O; Khalifa A
    J Urol; 2002 Aug; 168(2):465-9. PubMed ID: 12131289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The bladder tumor antigen (BTA) test compared to voided urine cytology in the detection of bladder neoplasms.
    Murphy WM; Rivera-Ramirez I; Medina CA; Wright NJ; Wajsman Z
    J Urol; 1997 Dec; 158(6):2102-6. PubMed ID: 9366322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiplex protein signature for the detection of bladder cancer in voided urine samples.
    Rosser CJ; Ross S; Chang M; Dai Y; Mengual L; Zhang G; Kim J; Urquidi V; Alcaraz A; Goodison S
    J Urol; 2013 Dec; 190(6):2257-62. PubMed ID: 23764080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CCL18 in a multiplex urine-based assay for the detection of bladder cancer.
    Urquidi V; Kim J; Chang M; Dai Y; Rosser CJ; Goodison S
    PLoS One; 2012; 7(5):e37797. PubMed ID: 22629457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance of nuclear matrix protein 22 urine marker and voided urine cytology in the detection of urinary bladder tumors.
    Smrkolj T; Mihelič M; Sedlar A; Sterle I; Osredkar J; Sedmak B
    Clin Chem Lab Med; 2011 Feb; 49(2):311-6. PubMed ID: 21118051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bladder cancer risk stratification using a urinary mRNA biomarker panel - A path towards cystoscopy triaging.
    Shkolyar E; Zhao Q; Mach KE; Teslovich NC; Lee TJ; Cox S; Skinner EC; Lu Y; Liao JC
    Urol Oncol; 2021 Aug; 39(8):497.e9-497.e15. PubMed ID: 33766467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human complement factor H related protein test for monitoring bladder cancer.
    Raitanen MP; Marttila T; Nurmi M; Ala-Opas M; Nieminen P; Aine R; Tammela TL;
    J Urol; 2001 Feb; 165(2):374-7. PubMed ID: 11176376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary miRNAs as a Diagnostic Tool for Bladder Cancer: A Systematic Review.
    Grimaldi AM; Lapucci C; Salvatore M; Incoronato M; Ferrari M
    Biomedicines; 2022 Oct; 10(11):. PubMed ID: 36359288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Raman chemometric urinalysis (Rametrix) as a screen for bladder cancer.
    Huttanus HM; Vu T; Guruli G; Tracey A; Carswell W; Said N; Du P; Parkinson BG; Orlando G; Robertson JL; Senger RS
    PLoS One; 2020; 15(8):e0237070. PubMed ID: 32822394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multi-analyte assay for the non-invasive detection of bladder cancer.
    Goodison S; Chang M; Dai Y; Urquidi V; Rosser CJ
    PLoS One; 2012; 7(10):e47469. PubMed ID: 23094052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of telomerase activity and matrix metalloproteinase-9 in voided urine and bladder wash samples as a useful diagnostic tool for bladder cancer.
    Eissa S; Labib RA; Mourad MS; Kamel K; El-Ahmady O
    Eur Urol; 2003 Dec; 44(6):687-94. PubMed ID: 14644121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Routine follow-up cystoscopy in detection of recurrence in patients being monitored for bladder cancer.
    Raitanen MP; Leppilahti M; Tuhkanen K; Forssel T; Nylund P; Tammela T;
    Ann Chir Gynaecol; 2001; 90(4):261-5. PubMed ID: 11820414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The diagnostic efficacy of urinary TGF-beta1 and VEGF in bladder cancer: comparison with voided urine cytology.
    Eissa S; Salem AM; Zohny SF; Hegazy MG
    Cancer Biomark; 2007; 3(6):275-85. PubMed ID: 18048965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Novel Urine-Based Assay for Bladder Cancer Diagnosis: Multi-Institutional Validation Study.
    Davis N; Shtabsky A; Lew S; Rona R; Leibovitch I; Nativ O; Cohen M; Mor Y; Lindner U; Glickman Y; Matzkin H; Tsivian A; Gofrit O; Yossepovitch O
    Eur Urol Focus; 2018 Apr; 4(3):388-394. PubMed ID: 28753799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.